Trial intelligence / Profile preview

Domperidone for vomiting due to acute gastroenteritis in pediatric patients

2015-002923-24Phase 3Terminated

Sponsor
Janssen Pharmaceutical
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute gastroenteritis comparing Domperidone plus oral rehydration therapy with Placebo plus oral rehydration therapy (2 arms). Started Mar 2016; status: terminated.

02

Drugs

domperidone
03

Conditions

acute gastroenteritis

Beyond the preview

Go deeper on 2015-002923-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002923-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call